Bcl-2 expression in primary uveal melanoma

• Published in: Tumori 2001-01, Vol.87 (1), p.54-57
• Main Authors: Sulkowska, M, Famulski, W, Bakunowicz-Lazarczyk, A, Chyczewski, L, Sulkowski, S
• Format: Article
• Language: English
• Subjects: Female; Gene Expression Regulation, Neoplastic; Humans; Male; Melanoma - chemistry; Melanoma - pathology; Middle Aged; Proto-Oncogene Proteins c-bcl-2 - analysis; Uveal Neoplasms - chemistry; Uveal Neoplasms - pathology
• ISSN: 0300-8916; 2038-2529
• DOI: 10.1177/030089160108700112

Uveal malignant melanoma is the most common intraocular tumor. The aim of this study was the analysis of bcl-2 oncoprotein expression in this tumor type. The melanomas were evaluated according to tumor location and patient age and sex. The relationship between bcl-2 expression and histological type, clinicopathologic stage and the presence of a set of predetermined morphological parameters was analyzed. The study involved 39 patients with ocular melanomas treated with surgery alone between 1983 and 1997. Formalin-fixed, paraffin-embedded tissues were treated with anti-bcl-2 antibody (Dako No M0887). Immunolocalization of the bcl-2 oncoprotein was performed using the labeled streptavidin biotin (LSAB) method. bcl-2 expression in neoplastic cells was evaluated in a semiquantitative manner: lack of reactivity was defined as bcl-2 negative, reactivity present in less than 30% of cells as low bcl-2, and reactivity in more than 30% of cells as high bcl-2. The percentage of cells with a positive reaction was assessed independently by two pathologists, and the results were subjected to statistical analysis using Fischer's exact test. No statistically significant correlation was found between the expression of bcl-2 oncoprotein and the clinicopathologic features analyzed. However, the high percentage of tumors with positive expression of this oncoprotein suggests that it plays a significant role in the biology of uveal melanoma.